{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:25:50Z","timestamp":1781785550751,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jri.2020.103205","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T12:43:10Z","timestamp":1603284190000},"page":"103205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Understanding HLA-G driven journey from HPV infection to cancer cervix: Adding missing pieces to the jigsaw puzzle"],"prefix":"10.1016","volume":"142","author":[{"given":"Ritu","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhulika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Mangat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana","family":"Minz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2020.103205_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2015.05.029","article-title":"Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: a case-control study","volume":"138","author":"Aggarwal","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jri.2020.103205_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12307-012-0097-8","article-title":"Location and density of immune cells in precursor lesions and cervical cancer","author":"Bedoya","year":"2013","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.jri.2020.103205_bib0015","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2007-12-127662","article-title":"Beyond the increasing complexity of the immunomodulatory HLA-G molecule","volume":"111","author":"Carosella","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jri.2020.103205_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","article-title":"HLA-G: from biology to clinical benefits","volume":"29","author":"Carosella","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jri.2020.103205_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/fon.09.8","article-title":"HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer","volume":"5","author":"de Araujo Souza","year":"2009","journal-title":"Future Oncol."},{"key":"10.1016\/j.jri.2020.103205_bib0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/1933719110369183","article-title":"Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16\/18 infection, and host immune response","volume":"17","author":"Dong","year":"2010","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jri.2020.103205_bib0035","first-page":"125","article-title":"Human leukocyte Antigen-G (HLA-G) expression in precancerous and cancerous cervical lesions: association with human papilloma virus infection and host immune response","volume":"25","author":"Fahim","year":"2018","journal-title":"Egypt. J. Immunol."},{"key":"10.1016\/j.jri.2020.103205_bib0040","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jri.2020.103205_bib0045","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/315086","article-title":"Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high\u2010risk area for cervical cancer","volume":"180","author":"Franco","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jri.2020.103205_bib0050","article-title":"The role of the immune system in anogenital human papillomavirus","author":"Frazer","year":"1998","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.jri.2020.103205_bib0055","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bbcan.2014.10.004","article-title":"Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: a candidate molecule for therapeutic intervention and prognostic biomarker?","volume":"1846","author":"Gimenes","year":"2014","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"key":"10.1016\/j.jri.2020.103205_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejogrb.2008.06.010","article-title":"Classical and non-classical HLA molecules and p16 INK4a expression in precursors lesions and invasive cervical cancer","volume":"141","author":"Gon\u00e7alves","year":"2008","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.jri.2020.103205_bib0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1593\/neo.05703","article-title":"Soluble HLA-G molecules are increased during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages","volume":"8","author":"Gros","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.jri.2020.103205_bib0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1369\/jhc.2009.954131","article-title":"Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV)","volume":"58","author":"Guimar\u00e3es","year":"2010","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.jri.2020.103205_bib0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0168-1702(02)00191-0","article-title":"Host and viral genetics and risk of cervical cancer: a review","volume":"89","author":"Hildesheim","year":"2002","journal-title":"Virus Res."},{"key":"10.1016\/j.jri.2020.103205_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/156800907780006869","article-title":"Mechanisms used by human papillomaviruses to escape the host immune response","volume":"7","author":"Kanodia","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jri.2020.103205_bib0085","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1158\/1078-0432.CCR-05-0456","article-title":"Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"11","author":"Leleu","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jri.2020.103205_bib0090","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","article-title":"Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells","volume":"109","author":"LeMaoult","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jri.2020.103205_bib0095","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.humimm.2012.07.041","article-title":"Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression","volume":"73","author":"Li","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jri.2020.103205_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200202150-00005","article-title":"Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule","volume":"16","author":"Lozano","year":"2002","journal-title":"Aids"},{"key":"10.1016\/j.jri.2020.103205_bib0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00726-013-1494-0","article-title":"Analysis of the formalin-fixed paraffin-embedded tissue proteome: pitfalls, challenges, and future prospectives","volume":"45","author":"Maes","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.jri.2020.103205_bib0110","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.95.8.4510","article-title":"HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance","volume":"95","author":"Paul","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jri.2020.103205_bib0115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1044-579X(03)00028-2","article-title":"Secretion of sHLA-G molecules in malignancies","volume":"13","author":"Rebmann","year":"2003","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jri.2020.103205_bib0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000334089","article-title":"Altered HLA class i and HLA-G expression is associated with IL-10 expression in patients with cervical cancer","volume":"79","author":"Rodr\u00edguez","year":"2012","journal-title":"Pathobiology"},{"key":"10.1016\/j.jri.2020.103205_bib0125","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3892\/ol.2015.3295","article-title":"Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer (Review)","volume":"10","author":"Song","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jri.2020.103205_bib0130","first-page":"16","article-title":"Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies","volume":"53","author":"Tota","year":"2011","journal-title":"Prev. Med. (Baltim.)"},{"key":"10.1016\/j.jri.2020.103205_bib0135","first-page":"1","article-title":"Human papillomavirus infections in newly sexually","author":"Winer","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jri.2020.103205_bib0140","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0952-7915(94)90079-5","article-title":"Immunology of the human papilloma virus in relation to cancer","volume":"6","author":"Wu","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jri.2020.103205_bib0145","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1086\/604733","article-title":"Induction of both membrane\u2010bound and soluble HLA\u2010G expression in active human cytomegalovirus infection","volume":"200","author":"Yan","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jri.2020.103205_bib0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejca.2013.10.018","article-title":"Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women","volume":"50","author":"Yang","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jri.2020.103205_bib0155","first-page":"1","article-title":"The role of TLRs in cervical cancer with HPV infection: a review","volume":"2","author":"Yang","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jri.2020.103205_bib0160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1399-0039.2010.01607.x","article-title":"Up-regulation of HLA-G expression in cervical premalignant and malignant lesions","volume":"77","author":"Zheng","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jri.2020.103205_bib0165","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.lfs.2005.10.039","article-title":"Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma","volume":"78","author":"Zhou","year":"2006","journal-title":"Life Sci."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037820301261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037820301261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:31:54Z","timestamp":1759033914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037820301261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":33,"alternative-id":["S0165037820301261"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2020.103205","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding HLA-G driven journey from HPV infection to cancer cervix: Adding missing pieces to the jigsaw puzzle","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2020.103205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103205"}}